Back
Incyte Vs. Allogene Therapeutics Industry Stock Comparison
Buy
64
INCY
Incyte
Last Price:
77.29
Seasonality Move:
35.45%
Buy
59
ALLO
Allogene Therapeutics
Last Price:
3.00
Seasonality Move:
-10.11%
Buy
64
Incyte (INCY)
is a Buy
Is Incyte a Buy, Sell or Hold?
- The current Incyte [INCY] share price is $77.28. The Score for INCY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- INCY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Allogene Therapeutics (ALLO)
is a Buy
Is Allogene Therapeutics a Buy, Sell or Hold?
- The current Allogene Therapeutics [ALLO] share price is $2.99. The Score for ALLO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ALLO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALLO Stock Price Chart
What is Allogene Therapeutics's stock price today?
-
The Allogene Therapeutics share price today is $2.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALLO is experiencing slight buying pressure.
INCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.72 | Buy |
| Relative Strength Index (14 RSI): | 80.26 | Buy |
| Chaikin Money Flow: | 1140547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.25 - 72.25) | Buy |
| Bollinger Bands (100): | (61.18 - 68.26) | Buy |
ALLO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 58.5 | Buy |
| Chaikin Money Flow: | 974664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 2.83) | Buy |
| Bollinger Bands (100): | (2.39 - 2.91) | Buy |
INCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.7 | Buy |
| 20-day SMA: | 68.51 | Buy |
| 50-day SMA: | 66.46 | Buy |
| 200-day SMA: | 60.94 | Buy |
| 8-day EMA: | 73.42 | Buy |
| 20-day EMA: | 70.01 | Buy |
| 50-day EMA: | 67.15 | Buy |
| 200-day EMA: | 63.04 | Buy |
ALLO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.73 | Buy |
| 20-day SMA: | 2.72 | Buy |
| 50-day SMA: | 2.71 | Buy |
| 200-day SMA: | 3.18 | Sell |
| 8-day EMA: | 2.8 | Buy |
| 20-day EMA: | 2.74 | Buy |
| 50-day EMA: | 2.71 | Buy |
| 200-day EMA: | 3.09 | Sell |
Incyte Earnings Growth & INCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.29 per share, and an increase next year of $4.72 per share.
Allogene Therapeutics Earnings Growth & ALLO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.15 per share.
Incyte Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Allogene Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||